Understanding bleeding risks from blood thinners in cancer patients
Prediction of Anticoagulant-Related Bleeding Risk in Patients with Cancer
This study is looking to create a helpful tool that can predict which cancer patients on blood thinners might be at risk for serious bleeding, so doctors can make safer choices about their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10983348 on NIH RePORTER |
What this research studies
This research aims to develop a predictive model to assess the risk of major bleeding in cancer patients who are receiving anticoagulant therapy. Given that patients with cancer face a significantly higher risk of bleeding compared to those without cancer, the study will analyze various factors to create an evidence-based approach for managing anticoagulant use. By identifying patients at high risk for bleeding, healthcare providers can make more informed decisions about anticoagulant therapy, potentially reducing unnecessary risks while still preventing blood clots. The research will involve collecting data from cancer patients on anticoagulants and calibrating the predictive model based on their unique health profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are currently receiving anticoagulant therapy for conditions such as venous thromboembolism.
Not a fit: Patients who are not on anticoagulant therapy or those without a cancer diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer anticoagulant management for cancer patients, reducing the incidence of life-threatening bleeding events.
How similar studies have performed: While there are existing models for predicting bleeding risk in non-cancer populations, this research is novel as it focuses specifically on cancer patients, addressing a significant gap in current medical knowledge.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Sanfilippo, Kristen Marie — Washington University
- Study coordinator: Sanfilippo, Kristen Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.